Ecstasy (MDMA) Use During Pregnancy: Risks to Mother and Baby
Ecstasy (MDMA) is a synthetic stimulant with hallucinogenic properties. Use at any stage of pregnancy poses serious risks to fetal development and maternal health.
Documented Risks
- Neural tube defects: Increased risk of spina bifida, anencephaly.
- Placental abruption: Life‑threatening separation of placenta.
- Preeclampsia: Dangerous high blood pressure and proteinuria.
- Low birth weight: Associated with developmental delays.
- Neonatal withdrawal: Tremors, irritability, feeding difficulties.
- Maternal mental health decline: Anxiety, depression, paranoia.
- Long‑term child effects: Impulsivity, attention deficits, memory impairments.
Critical Advice
Abstain completely from ecstasy and all recreational drugs during pregnancy. Discuss any substance use honestly with your prenatal provider for optimal care.
Pregnancy & Health - Related Articles
- Fundal Height at 27 Weeks: 29 cm Measurement — Interpretation & Next Steps
- Tiling During Pregnancy: Safety Tips and Precautions
- Managing 6‑7‑Week Pregnancy: Heartbeat, Pain, and Spotting Concerns
- Understanding Fetal Ultrasound: How Images Are Created
- Alcohol in Pregnancy: Fetal Alcohol Spectrum Disorders and Other Risks
- Can the Morning-After Pill Cause Miscarriage at 1 Month Pregnancy?
- Pregnancy Despite Period and Negative Test: Causes and Next Steps
